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JOHN SCOTT HALDANE REPORTED the narcotic effect of carbon dioxide was a limiting factor for divers when helmet ventilation was inadequate, resulting in CO 2 accumulation with exercise intolerance and unconsciousness ("deep water blackout") (4, 20, 25) . Normal function was possible when breathing an inspired CO 2 partial pressure (PI CO 2 ) of 0.03 ata, but PI CO 2 in excess of 0.04 atm limited work capacity, and unconsciousness was almost certain above a PI CO 2 of 0.1 atm.
During the Second World War, British Navy combat divers using oxygen rebreathers would occasionally lose consciousness in less than 6 m of sea water (msw, 1.6 ata), which appeared too shallow for oxygen toxicity according to experimental trials (4, 10, 11) . This phenomenon was described as "shallow water blackout", 1 which was hypothesized to result from the narcotic properties of CO 2 that were exacerbated by high inspired oxygen partial pressures (PI O 2 ). To investigate this hypothesis, Donald (10, 11) had volunteers exercise at sea level while rebreathing oxygen with or without CO 2 absorption. The exposures were terminated by vertigo, tremors, loss of balance, dissociation, unconsciousness, weakness, cyanosis, or inability to stand. Respiratory distress was minimal or absent despite high ventilation rates and mean inspired CO 2 partial pressures of 0.068 -0.128 atm corresponding to mean CO 2 partial pressures in the counterlung of 0.051-0.081 atm. For operational purposes, it was concluded, "that the chief factor in shallow water blackout is carbon dioxide intoxication" (4) , but the influence of PI O 2 could not be known as Donald had conducted no normoxic controls (10, 11) . Our objective was to repeat this work with a full set of controls to investigate the secondary role of PI O 2 on CO 2 intoxication.
The adverse effect of hypercapnia on cognitive or psychomotor performance has been demonstrated in various studies (13, 23, 24, 42) , but only one investigated a possible interaction between O 2 and CO 2 , and there were no performance decrements in postural sway, tremor, hand steadiness, simple reaction time, or choice reaction time with either normoxia or hyperoxia for gases containing a PI CO 2 of 0.06 atm (22) .
The effect of hyperoxic hypercapnia on consciousness in divers remains relevant because of CO 2 retention during underwater exercise (8, 15, 38) , especially with closed-circuit rebreathers where CO 2 can be present in the inspired gas. Symptoms suggestive of oxygen toxicity were reported in Israeli Navy combat swimmers using rebreathers at 3-6 msw (1), although the low PI O 2 at these shallow depths (1.1-1.2 atm) (21) indicated hypercapnia as the causative agent. Hypercapnia alone impairs cognition in divers (48) , occasionally with fatal results (34) . Here we describe the results of an investigation of the effects of hyperoxia on respiratory function and cognitive performance in volunteers who breathed hypercapnic gas to test the hypothesis that hyperoxia potentiates CO 2 intoxication.
METHODS

Subjects.
The Institutional Review Board of Duke University Medical Center approved the study, subjects provided informed consent, and a medical history review with a baseline physical examination by a hyperbaric physician ensured they were healthy. Sixteen male volunteers were recruited from among local certified scuba divers or people who had previous hypo/hyperbaric chamber experience at the laboratory. Women were not included because of variations in hypercapnic ventilatory response (HCVR) during the menstrual cycle (35, 43) . Body fat composition of Ͻ20% was required as estimated by seven-site skinfold measures (33) .
Assessment of cognitive function. Cognitive function was assessed with an auditory n-back test (27) , which has consistently been found to activate frontal and parietal cortical regions in a meta-analysis of 24 studies and is a standard for evaluating working memory (37) . The test presented subjects with a train of long (200 ms) and short (100 ms) tones of random frequency separated by 1-s intervals. Subjects were required to identify the length of the most recent tone as equal to or different from the previous tone. For subjects who consistently exceeded 90%, a higher level of difficulty was introduced by asking for comparison of the most recent tone with a tone 2-3 stimuli earlier (the "n" in n-back). Subjects trained until they could achieve 80 -90% correct responses.
Determination of the highest tolerable inspired CO 2 limit. There was wide variability of CO2 tolerance among subjects. The highest tolerable limit was determined for each subject from among gases containing 0.065, 0.075, and 0.085 atm PICO 2 . (These gases were blended from pure N2, O2, and CO2.) Each gas of progressively increasing CO2 concentration was inspired for 6 min separated by a 6-min interval breathing CO2-free gas to allow recovery (Table 1) . Tolerance limits were determined separately with subjects seated at rest or seated on a bicycle ergometer and exercising at 75 W. Previous work had shown that ventilation approaches steady state in 4 min (18) . All gases used to test CO 2 tolerance were normoxic (PIO 2 ϭ 0.21 atm). The O2 and CO2 content in the test gases were within 0.0032 and 0.0007 atm, respectively, of their desired partial pressures.
A subject seated on a bicycle ergometer inside a hyperbaric chamber was fitted with a 3-lead EKG, nose clips, a Hans-Rudolph 2700 mouthpiece, headphones for the n-back test, and a touch screen computer monitor (ELO monitor, Touchsystems, Menlo Park, CA) on which to record the n-back test responses (Fig. 1) . Mouthpiece pressure was measured by a Validyne MP40 pressure transducer, and a sample line attached to the mouthpiece withdrew a continuous gas sample for analysis by a mass spectrometer (model 1100 medical gas analyzer, Perkin-Elmer, Pomona, CA). An attendant switched the breathing gas mixtures and administered the n-back tests. The chamber was compressed to a pressure of 1.45 atmospheres absolute (ata), equivalent to 4.6 msw.
The inspiratory hose from the mouthpiece was connected to Douglas bags via a valve box assembly with which breathing gases could be selected. The expiratory hose was coupled to a Fleisch #4 pneumotachometer for measuring pulmonary ventilation. The pressure transducer, mass spectrometer, and pneumotachometer were connected to a computer outside the chamber with Labview (version 6.1, National Instruments, Austin, TX). A data acquisition board (PCI 6014, National Instruments) was also used with Labview from which ECG and CO 2 waveforms (PETCO 2 ) were obtained.
The pressure transducer, pneumotachometer, and mass spectrometer were calibrated at pressure from ϩ50 to Ϫ50 cmH 2O using an electronic manometer (Sper Scientific, Scottsdale, AZ), a 3-liter syringe and gasometer (model DTM 325-4, American Meter, Nebraska City, NE), and three premixed gas samples of known O 2 and CO2 concentration. After instrument calibration, the subject breathed ambient chamber air through the mouthpiece while performing a practice n-back test battery. This was followed by the test gases in Table 1 until the maximum tolerable PI CO 2 or 0.085 atm was achieved. Separate tolerance tests were conducted at rest and with 75 W exercise. At the end of each breathing period, the subject was asked to report a rating of perceived discomfort (RPD) on a 0 -10 visual analog scale with zero being no discomfort and 10 being the maximum tolerable discomfort. At the end of each breathing period the subject reported any symptoms that had occurred.
Determination of hyperoxic and hypercapnic effects. These procedures were similar to those described above except for the pattern of breathing gases. Four gases were presented to the subject (Table 2) : gas A, a normoxic control with no CO 2; gas B, an experimental gas with an oxygen partial pressure of 1.3 atm and no CO2; gas C, a normoxic experimental gas containing the tolerable CO2 limit for that subject; and gas D, a hyperoxic, hypercapnic experimental gas with a PIO 2 of 1.3 atm and the tolerable CO2 limit. A PIO 2 of 1.3 atm was selected because this approaches the highest value believed to have a very low probability of causing central nervous system oxygen toxicity (45) and is the value used in the US Navy Mk 16 closed-circuit mixed gas breathing apparatus (44a).
Subjects were tested on three different days. On each day the subject was presented with three pairs of gases, for example, AB, AC, and AD, in which each experimental gas was preceded by a control gas to return the subject to steady state before breathing the next experimental gas. The 6-min washout period with control gas A before Order of gas administration, from lowest to highest CO2 concentration. Each CO2 exposure was preceded by a 6-min, normoxic, normocapnic control gas. Time indicates start time for each gas breathing period. each experimental gas reduced the carryover effects from the previous experimental gas. To eliminate an effect of experimental gas order, the presentation of gas pairs was randomized in a Latin square design on the three separate days as illustrated in Table 3 (12). The seated subject was fitted with mouthpiece and headphones ( Fig. 1) and completed a practice n-back test battery while breathing chamber air during instrument calibration. The subject, attendant, and investigators were blinded to the gas breathed and the order of the gas pairs (Table 3 ). Each gas was breathed for 6 min. The first 2 min allowed the previous gas to be washed out of the circuit and PET CO 2 to reach steady state before a 4-min n-back test period. Respiratory parameters for each gas were reported as the means of those recorded during the last 30 s of the 6-min period. Subjects were exposed at the same time of day to control for diurnal variation in HCVR. Recorded data included symptoms, symptom severity score (RPD), inspiratory and expiratory mouthpiece pressure, PET CO 2 , PETO 2 , pulmonary ventilation (V E), and heart rate.
Experiments were repeated on a separate day with subjects pedaling on a cycle ergometer at a work rate of 75 W. Exercising subjects were allowed an extra 2 min of rest after each exercise bout, but there were no other differences between resting and exercising trials.
Statistical analysis. The crossover, randomized Latin square design allowed each subject to serve as his own statistical control while permitting designed manipulation of potentially confounding factors and their interactions (sequence order, CO 2 tolerance level, and individual n-back difficulty). Effects on outcomes were modeled by repeated-measures multiple linear regression (SAS Version 9.1, Cary, NC). Outcome variables of interest were V E, PETCO 2 , RPD, and n-back.
Analysis was conducted with two objectives: 1) to investigate how outcomes varied with PET CO 2 as a continuous and homogeneous predictor and with PIO 2 as a binary predictor and 2) to investigate how hyperoxia independently affected outcomes for normocapnic gases (A and B) and for hypercapnic gases (C and D). The second analysis was conducted in the event that the heterogeneity of subject CO 2 tolerance distorted the relationships of PETCO 2 to outcomes in the first analysis.
Differences in the incidence of serious symptoms for gases C and D were evaluated by a two-tailed Fisher's exact test. Significance was accepted at P Ͻ 0.05.
RESULTS
Subjects.
Four of the 16 volunteers declined to finish the lengthy n-back training and withdrew. The remaining 12 completed the resting phase of the study, and 10 of these completed the exercise phase. The physical characteristics of those who completed the trials are shown in Table 4 .
The n-back and CO 2 tolerance limits for each subject are listed in Table 5 . The mean maximum PI CO 2 tolerated by the 12 resting subjects was 0.081 Ϯ 0.007 atm (61.6 mmHg) and 0.074 Ϯ 0.12 atm (56.2 mmHg) for the 10 exercising subjects. CO 2 tolerance decreased with age (P Ͻ 0.0001). During exposure to gas C (normoxic hypercapnia), Subject 1 developed serious symptoms (Table 6 ) at a PI CO 2 of 0.075 atm (57.0 mmHg), and his subsequent resting trials were conducted with PI CO 2 of 0.065 atm (49.4 mmHg). This was also true for Subject 3, and his PI CO 2 was reduced from 0.085 to 0.075 atm for rest and from 0.065 to 0.055 atm during exercise. Figure 2 , A-C, illustrates raw data for n-back, RPD, and V E as functions of PET CO 2 independent of PI O 2 for resting subjects. Linear regression lines were fit to the raw data as visual aids but do not reflect the repeated-measures analysis.
Correlation of V E, RPD, and n-back with PET CO 2 .
n-Back score was negatively, but modestly, correlated with PET CO 2 (P Ͻ 0.0001), with n-back decreasing (reduced performance) at 0.51 (rest) and 0.58 (exercise) %/mmHg ( Fig. 2A) . With PET CO 2 as the predictor variable, n-back was unaffected by PI O 2 but was negatively correlated with age at 0.27%/yr for rest (data not shown). There was no age effect with exercise (data not shown).
RPD was positively correlated with PET CO 2 for rest and exercise. There was an interaction between PI O 2 and PET CO 2 , but PI O 2 was not significant for exercise. The increase in RPD was greatest at low values of PET CO 2 where dyspnea was minimal. RPD was also associated with age for both rest and exercise (P ϭ 0.0001). RPD increased by 0.06 units per year of age (rest) and 0.08 (exercise). Peak-to-peak mouthpiece pressures did not exceed 7 mbar, well within the European Union Standard for Personal Protection Equipment (EN14143:2003).
V E was strongly associated with both PI O 2 and PET CO 2 (P Ͻ 0.0001), with V E increasing at 1.77 (rest) and 1.39 (exercise) Arrows indicate subjects who changed from a higher to lower CO2 tolerance gas after they developed serious manifestations. *Did not complete exercise phase. l·min Ϫ1 ·mmHg Ϫ1 . V E increased by 8.8 (rest) and 9.4 (exercise) l/min when the PI O 2 was raised from 0.21 to 1.3 atm. V E was also correlated with age (P ϭ 0.0124 for rest, P ϭ 0.0042 for exercise) increasing by 0.25 l·min Ϫ1 ·yr Ϫ1 with rest and 0.33 with exercise (data not shown).
Correlation of V E, RPD, n-back, and PET CO 2 with hyperoxia. The previous analysis found, as expected, that rising PET CO 2 was associated with increased ventilation, greater discomfort, and reduced performance but failed to detect an influence of hyperoxia on RPD or n-back. The analysis described below evaluated the effect of hyperoxia on the normocapnic gases (A and B) and hypercapnic gases (C and D). PET CO 2 was treated as an outcome rather than a predictor to characterize the effect of PI O 2 on PET CO 2 (Table 6) . V E was 2-4 l/min higher with hyperoxic inspired gases under all conditions (except for gases C and D at rest), whereas PET CO 2 was 3-4 mmHg lower with hyperoxic gases for both rest and exercise. RPD was significantly less by 0.5 units for hyperoxic, hypercapnic gases with exercise but not for rest or normocapnic gases. n-Back scores improved by 3-4% for both hyperoxic gases with rest and exercise.
Clinical manifestations. Subjects completed 66 hyperoxic hypercapnic trials (gas D) without incident, but in 69 normoxic hypercapnic trials (gas C), five subjects experienced serious symptoms. Five serious events in 69 trials (7.2%) of gas C with 0.21 ATA PI O 2 (including the 3 aborted trials) differed from no serious events in 66 trials of gas D with 1.3 ATA PI O 2 at P ϭ 0.0582 (2-tail Fisher's exact test). Although serious symptoms were exclusively associated with normoxic hypercapnia (gas C), the P value was above the accepted level of 0.05 for statistical significance, indicating a trend rather than significance.
Commonly reported symptoms included respiratory distress, hyperpnea, and posttrial headache. The serious symptoms reported by five subjects (Table 7) included tunnel vision, vision loss, dizziness, panic, exhaustion, or near-syncope while breathing gas C (0.21 atm O 2 at the individual limit of hypercapnic tolerance). Three of these trials could not be completed (Subject 1 at rest, Subject 3 during rest and exercise), whereas two trials were completed (Subjects 8 and 16 during exercise) but with near loss of consciousness.
Normoxic hypercapnia (gas C) was the only test gas to produce serious symptoms. Subjects 1 and 3 subsequently completed a full series of trials with a lower PI CO 2 (Tables 5  and 7 ). Table 7 summarizes measurements for all trials on gases C and D for subjects who developed serious symptoms. PET CO 2 was higher for normoxic hypercapnia (gas C) than for hyperoxic hypercapnia (gas D) and highest when there were serious symptoms. RPD was generally greatest for normoxic hypercapnia (gas C) than for hyperoxic hypercapnia (gas D), and n-back was generally lower. V E did not fit the pattern seen in Fig. 2C , however, and was often lower for hyperoxic hypercapnia (gas D) than for normoxic hypercapnia (gas C).
DISCUSSION
Individual tolerance for PI CO 2 varied widely (0.055-0.085 atm) among our subjects, suggesting that CO 2 exposure safety cannot be characterized by a single value. We might have chosen the lowest maximum PI CO 2 all subjects could tolerate, and this would have simplified interpretation and analysis, but the most CO 2 -resistant individuals would have contributed no information to the study. Instead, we chose the maximum PI CO 2 tolerated by each individual as a measure of population heterogeneity because this provided the most information. Henning et al. (22) and Sheehy et al. (44) found no performance effects with hyperoxia, perhaps because they used lower values of PI O 2 and PI CO 2 than did we or because the n-back test was more sensitive. Ideally, the study would have been conducted over a range of PI CO 2 values for each subject. Had such an approach been practical, separate relationships such as in Fig. 2 could have been plotted for each subject rather than treating all PI CO 2 values as though they pertained to the same subject. Lacking such detailed information, we used binary tests that evaluated the effect of hyperoxia on pairs of gases with and without hypercapnia. The results of this analysis appeared to be relatively unambiguous (Table 6 ): when PI O 2 was raised from 0.21 to 1.3 atm, V E increased in hypercapnia (except for resting hypercapnia), whereas PET CO 2 decreased under all conditions. RPD improved for hypercapnia with exercise (although not for rest), whereas n-back scores improved for both rest and exercise with hypercapnia. These observations were consistent with a straightforward interpretation: hyperoxia increased ventilation; increased ventilation eliminated more CO 2 , thereby reducing PET CO 2 ; and there was less discomfort and improved performance with reduced PET CO 2 . It should be noted, however, as Hesser et al. (24) and Sayers et al. (42) have suggested, performance (e.g., n-back scores) may be affected by the increased discomfort (e.g., higher RPD) that accompanies rising PET CO 2 (Fig. 2, A and B) . Indeed, a study by BlochSalisbury suggests that EEG may be more sensitive to inspired CO 2 than cognitive performance (7) . Figure 2C illustrates a robust, positive correlation of V E with PET CO 2 for resting subjects even when PET CO 2 was treated as pertaining to a single subject. A smaller but significant increase of 8 -9 l/min in V E was noted when PI O 2 was raised from 0.21 to 1.3 atm. (Observations were similar for exercise.) Increased ventilation and decreased PET CO 2 has been a common finding under both isocapnic and poikilocapnic conditions (5, 6, 18, 26) , but hyperoxia has also been observed to attenuate ventilation associated with hypercapnia and ventilation during exercise in a hyperbaric environment (15, 18, 38) consistent with finding that both arterial and mixed venous CO 2 values were higher in hyperoxia (15, 38) . Our PET CO 2 values, on the other hand, were consistently lower in hyperoxia (Table 6 ). Both these results are consistent with the direction of the change in ventilation.
There are several possible explanations for the higher ventilation and lower PET CO 2 in our study as opposed to the lower ventilation and higher arterial and mixed venous CO 2 in the Fraser et al. and Peacher et al. studies (15, 38) . Our PI O 2 was only 1.3 atm, whereas Fraser and Peacher and colleagues used 1.75 atm. Perhaps the effect of hyperoxia is dose dependent such that the responsiveness of the carotid body to hypercapnia is attenuated at 1.75 atm but not at 1.3 atm (38) . However, Gelfand and Lambertsen (18) found a decrease in ventilation and increase in alveolar PCO 2 with an alveolar PO 2 of only 0.88 atm (18) . Moreover, Cherry et al. (8) did not observe any significant decrease in Pa CO 2 at PO 2 ϭ 1.3 atm (8) .
It has been proposed that hyperoxia can cause an increase in ventilation because of the Haldane effect (5, 6). The explanation is that hyperoxia raises venous PO 2 and hence reduces the solubility of CO 2 in blood. Under constant metabolic conditions, this in turn would cause PCO 2 in the venous blood (and hence tissue) to rise, therefore stimulating ventilation via the central chemoreceptors. Indeed, under hypoxic conditions a small rise in PO 2 can induce a significant increase in venous PCO 2 due to the Haldane effect. However, during hyperoxia this effect is quite small (12) . Moreover, numerous studies of hyperoxic gas breathing in which arterial PCO 2 has been directly measured have failed to show a significant effect (14, 16,  28 -32, 36, 39 -41, 47, 49) . Thus it is likely that the apparent hyperventilation when using PET CO 2 as a surrogate for Pa CO 2 is a reflection of an alteration in the relationship between Pa CO 2 and PET CO 2 . The most likely explanation for the higher ventilation as a function of PET CO 2 (Fig. 2C ) when breathing 1.3 atm PO 2 is therefore a change in V E matching induced by hyperoxia. Wagner and colleagues (47) demonstrated that breathing 100% oxygen results in an effective increase in dead space. The result of this would be an increase in the arterial to end-tidal PCO 2 difference (Pa CO 2 Ϫ PET CO 2 ). During hyperoxia, PET CO 2 therefore underestimates Pa CO 2 , thus leading to an apparent increase in ventilation when plotted vs. PET CO 2 . A test of this hypothesis must wait for a study that measures both PET CO 2 and Pa CO 2 .
Gelfand and Lambertsen (18) and Dahan et al. (9) reported that hyperoxia appears to influence peripheral and central chemoreceptor control of ventilation with different time courses and amplitudes. We were unlikely to detect these effects, however, as our outcome measures were taken at the end of our 4 min exposures whereas the transients seen by Gelfand and Dahan had reached steady-state by about 4 min.
We found serious CO 2 toxicity symptoms occurred exclusively with normoxic hypercapnia although short of statistical significance. These observations were consistent with the higher ventilation rates and lower PET CO 2 that accompanied hyperoxia ( Table 6 ). The higher PET CO 2 associated with normoxia might well be expected to be associated with a higher probability of serious symptoms.
A review of two unpublished studies puts this observation in perspective. Gray et al. (19) investigated a self-rescue device for submerged helicopter crashes in which four subjects rebreathed air or 100% oxygen from a counterlung. While rebreathing air, dyspnea proceeded rapidly to voluntary termination, with subjects exhibiting cyanosis and ending with a PI O 2 ϭ 98.8 mmHg and a PI CO 2 ϭ 61.5 mmHg. During oxygen rebreathing, hypoxia was absent and dyspnea progressed more slowly with subjects reporting vertigo, marked confusion, near syncope, and mild euphoria that relieved the dyspnea with subjects ending with a PI O 2 ϭ 495.5 mmHg and a PI CO 2 ϭ 86.6 mmHg. The authors noted the subjects would have continued rebreathing had the test not been involuntarily terminated by a medical officer.
A second study found similar results in an investigation of breath-hold diving with air, 50% oxygen, or 100% oxygen for potential use in extending the dive time of special operations swimmers (46 Both studies sought to use oxygen to extend operational capabilities, but the authors concluded this was inadvisable due to safety concerns. With air breath-hold or rebreathing, hypoxia led to extreme discomfort and voluntary termination. With oxygen, hypoxia was absent, but hypercapnia was more extreme and the ability to judge when an exposure should be ended safely was compromised. In the study reported here, increased free ventilation with hyperoxia diminished hypercapnia, thereby reducing the probability of serious symptoms. The lack of free ventilation in the breath-hold and rebreathing studies made the reduction of PET CO 2 impossible.
Barlow and MacIntosh (4) concluded that elevated PET CO 2 was the main cause of shallow water blackout, and our findings support this conclusion. However, we also found evidence indicating that hyperoxia may not increase the risk of hypercapnia and serious CO 2 toxicity symptoms.
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